The serial technetium 99 (99Tc) bone scans of 76 patients with Stage D‐2 prostate cancers were reviewed. Sites of metastases in skeletal areas in decreasing order were vertebrae, ribs, pelvis, long bones, and skull. Patients with one or two involved skeletal areas had a significantly longer progression‐free interval and survival time than patients with three or more bony areas of uptake. Bone scans might be used as a stratification variable in future prospective clinical trials of Stage D‐2 prostate cancer.
|Original language||English (US)|
|Number of pages||5|
|State||Published - Jul 15 1991|
ASJC Scopus subject areas
- Cancer Research